Pharmaceutics

Sales of unapproved antibiotic formulations are rising in India, study finds

Sales of antibiotic fixed-dose combinations, including unapproved formulations, are rising in India, according to a study published in the British Journal of Clinical Pharmacology.…

FDA calls for label change on anti-diarrhoea drug to stem misuse by opioid users

US Food and Drug Administration calls for changes to how loperamide is packaged so that it can be sold in smaller quantities, for short-term use only.…

Life Sciences Industrial Strategy can help ensure the future of UK life sciences sector

The UK has some of the world’s most exciting science, a supportive business environment, and strong companies led by experienced management teams. It also has a unique ecosystem that is wider than just industry, with world-leading universities (the top two universities in the world), charity s…

Scientists rejecting UK over Brexit uncertainty

Science staff are rejecting the chance to work in the UK because of fears over Brexit, a senior figure at a major pharmaceutical firm has said.…

Pfizer may sell off consumer business

US pharmaceutical giant Pfizer has announced that it is likely to sell its consumer healthcare business.…

Puerto Rico hurricane damage could lead to drug shortages

The damage wreaked by Hurricane Maria in Puerto Rico in September 2017 could have serious repercussions for patients who rely on medicines and healthcare products manufactured there.…

Making drugs work better: four new drug delivery methods

New drug delivery methods have started to emerge that aim to improve efficacy, cost-effectiveness and adherence as well as reduce side effects.…

Making drugs work better: four new drug delivery methods

New drug delivery methods have started to emerge that aim to improve efficacy, cost-effectiveness and adherence as well as reduce side effects.…

Johnson & Johnson to pay US $417m damages in talc case

A woman in the US has been awarded US $417 million in punitive damages and compensation after a jury backed her claim that her terminal ovarian cancer was caused by using Johnson & Johnson (J&J) talc products, such as Baby Powder, for feminine hygiene, according to the Reuters news agency.…

Mylan to pay $465m in settlement over EpiPen

US drug manufacturer Mylan has agreed a US$465m settlement with the US Department of Justice in response to allegations that it overcharged the healthcare programme Medicaid for its anaphylaxis treatment EpiPen (epinephrine).…